234 related articles for article (PubMed ID: 31243652)
1. Insulin-like growth factor-1 and non-alcoholic fatty liver disease: a systemic review and meta-analysis.
Yao Y; Miao X; Zhu D; Li D; Zhang Y; Song C; Liu K
Endocrine; 2019 Aug; 65(2):227-237. PubMed ID: 31243652
[TBL] [Abstract][Full Text] [Related]
2. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.
Du SX; Lu LL; Geng N; Victor DW; Chen LZ; Wang C; Yue HY; Xin YN; Xuan SY; Jin WW
Lipids Health Dis; 2017 Dec; 16(1):228. PubMed ID: 29197393
[TBL] [Abstract][Full Text] [Related]
3. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Polyzos SA; Aronis KN; Kountouras J; Raptis DD; Vasiloglou MF; Mantzoros CS
Diabetologia; 2016 Jan; 59(1):30-43. PubMed ID: 26407715
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
Liang S; Cheng X; Hu Y; Song R; Li G
Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
[TBL] [Abstract][Full Text] [Related]
5. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Wang ST; Zheng J; Peng HW; Cai XL; Pan XT; Li HQ; Hong QZ; Peng XE
BMC Gastroenterol; 2020 Mar; 20(1):66. PubMed ID: 32164541
[TBL] [Abstract][Full Text] [Related]
6. Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ke Y; Liu S; Zhang Z; Hu J
Lipids Health Dis; 2021 May; 20(1):55. PubMed ID: 34034750
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis.
Potoupni V; Georgiadou M; Chatzigriva E; Polychronidou G; Markou E; Zapantis Gakis C; Filimidou I; Karagianni M; Anastasilakis D; Evripidou K; Ftergioti A; Togkaridou M; Tsaftaridis N; Apostolopoulos A; Polyzos SA
J Gastroenterol Hepatol; 2021 Nov; 36(11):3002-3014. PubMed ID: 34289181
[TBL] [Abstract][Full Text] [Related]
8. Circulating Insulin-like Growth Factor-1 Levels in Patients with Rheumatoid Arthritis: A Meta-analysis.
Zhao YL; Wu J; Zhang TP; Cheng QY; Wang XP; Gu MM; Pan HF; Ye DQ
Curr Pharm Des; 2019; 25(10):1091-1098. PubMed ID: 30892152
[TBL] [Abstract][Full Text] [Related]
9. Circulating insulin-like growth factor 1 and insulin-like growth factor binding protein-3 level in Alzheimer's disease: a meta-analysis.
Hu X; Yang Y; Gong D
Neurol Sci; 2016 Oct; 37(10):1671-7. PubMed ID: 27379655
[TBL] [Abstract][Full Text] [Related]
10. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Zhou Z; Chen H; Ju H; Sun M
Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of glucagon-like peptide 1 receptor agonists in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
Fan S; Shi X; Yao J; Zhong M; Feng P
Rev Esp Enferm Dig; 2020 Aug; 112(8):627-635. PubMed ID: 32496108
[TBL] [Abstract][Full Text] [Related]
12. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ren Q; Wang H; Zeng Y; Fang X; Wang M; Li D; Huang W; Xu Y
Lipids Health Dis; 2022 Mar; 21(1):27. PubMed ID: 35236351
[TBL] [Abstract][Full Text] [Related]
13. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a meta-analysis.
Madan SA; John F; Pyrsopoulos N; Pitchumoni CS
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1237-48. PubMed ID: 26193052
[TBL] [Abstract][Full Text] [Related]
15. Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis.
Wang X; Li W; Zhang Y; Yang Y; Qin G
Int J Clin Exp Med; 2015; 8(10):17221-34. PubMed ID: 26770315
[TBL] [Abstract][Full Text] [Related]
16. Association between platelet indices and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Li L; Yu J; Zhou Z
Rev Esp Enferm Dig; 2024 May; 116(5):264-273. PubMed ID: 36263810
[TBL] [Abstract][Full Text] [Related]
17. U-Shaped relationship of insulin-like growth factor I and incidence of nonalcoholic fatty liver in patients with pituitary neuroendocrine tumors: a cohort study.
Hu Y; Yuan C; Abdulnaimu M; Memetmin J; Jie Z; Tuhuti A; Abudueini H; Guo Y
Front Endocrinol (Lausanne); 2024; 15():1290007. PubMed ID: 38370349
[TBL] [Abstract][Full Text] [Related]
18. Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Han D; Chen J; Liu S; Zhang Z; Zhao Z; Jin W; Xin Y
J Clin Transl Hepatol; 2021 Aug; 9(4):484-493. PubMed ID: 34447677
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of orlistat in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Wang H; Wang L; Cheng Y; Xia Z; Liao Y; Cao J
Biomed Rep; 2018 Jul; 9(1):90-96. PubMed ID: 29930810
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease.
Liu S; Xiao J; Zhao Z; Wang M; Wang Y; Xin Y
J Clin Transl Hepatol; 2021 Feb; 9(1):3-14. PubMed ID: 33604250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
